Fgfr3 Is a Positive Regulator of Osteoblast Expansion and Differentiation During Zebrafish Skull Vault Development

J Bone Miner Res. 2020 Sep;35(9):1782-1797. doi: 10.1002/jbmr.4042. Epub 2020 May 26.

Abstract

Gain or loss-of-function mutations in fibroblast growth factor receptor 3 (FGFR3) result in cranial vault defects highlighting the protein's role in membranous ossification. Zebrafish express high levels of fgfr3 during skull development; in order to study FGFR3's role in cranial vault development, we generated the first fgfr3 loss-of-function zebrafish (fgfr3lof/lof ). The mutant fish exhibited major changes in the craniofacial skeleton, with a lack of sutures, abnormal frontal and parietal bones, and the presence of ectopic bones. Integrated analyses (in vivo imaging and single-cell RNA sequencing of the osteoblast lineage) of zebrafish fgfr3lof/lof revealed a delay in osteoblast expansion and differentiation, together with changes in the extracellular matrix. These findings demonstrate that fgfr3 is a positive regulator of osteogenesis. We conclude that changes in the extracellular matrix within growing bone might impair cell-cell communication, mineralization, and new osteoblast recruitment. © 2020 American Society for Bone and Mineral Research.

Keywords: CRANIAL VAULT DEFECTS; FGFR3; OSTEOBLASTS; OSTEOGENESIS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Osteoblasts
  • Osteogenesis
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics
  • Skull
  • Zebrafish Proteins / genetics
  • Zebrafish*

Substances

  • Zebrafish Proteins
  • Receptor, Fibroblast Growth Factor, Type 3
  • fgfr3 protein, zebrafish